The abstract is read at the publisher; the summary is JClub's.
Greatwall kinase is required for acute myeloid leukaemia (AML) cell proliferation, where its loss disrupts cytokinesis via a non-canonical pathway distinct from ENSA–PP2A-B55.
- Why it matters: Greatwall is linked to oncogenesis, but how it controls the cell cycle in malignancies beyond solid tumours—especially AML—was unclear.
- What they did: AML cells were tested with pharmacological and systematic genetic perturbations of Greatwall; ENSA–PP2A-B55 effects were assessed, and Greatwall substrates were mapped, including direct phosphorylation of MARK3.
- The result: Greatwall inactivation or depletion did not measurably affect ENSA–PP2A-B55, but it altered cytokinesis and cytoskeletal/cytokinesis protein phosphorylation, revealing a leukemic-specific Greatwall signalling network.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.